DR AGARWALS HEALTH CARE L (AGARWALEYE)

NSE: ₹465.00
BSE: ₹465.05
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 430.72 460.22 487.42 498.69 529.86 564.11
YOY Revenue Growth % - - - - 23.02% 22.57%
Other Income 12.71 15.43 13.39 7.93 10.54 12.58
Total Income 443.43 475.65 500.81 506.62 540.40 576.69
Total Expenses + 402.44 414.63 447.21 452.96 475.64 501.40
Cost of Materials Consumed 0.39 0.29 0.21 0.19 0.22 0.24
Employee Benefit Expense 83.87 87.14 95.52 99.12 105.36 103.79
Other Expenses 196.24 198.24 216.40 217.23 233.73 246.57
Operating Profit 28.28 45.59 40.21 45.73 54.22 62.71
OPM % 6.6% 9.9% 8.2% 9.2% 10.2% 11.1%
Profit Before Tax + 40.99 58.52 53.60 53.66 64.76 76.62
Tax Expense 12.75 15.97 15.54 17.17 21.13 26.66
Tax % 31.1% 27.3% 29% 32% 32.6% 34.8%
Profit After Tax 28.24 42.55 38.06 36.49 43.63 49.96
EPS (Basic) 0.73 1.04 0.95 0.94 1.07 1.25

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025
Revenue from Operations 2,080.08 1,711.00
YOY Revenue Growth % 21.57% -
Other Income 44.44 46.02
Total Income 2,124.52 1,757.02
Total Expenses + 1,877.21 1,594.15
Cost of Materials Consumed 0.86 1.18
Employee Benefit Expense 403.79 326.87
Other Expenses 913.93 765.65
Operating Profit 202.87 116.85
OPM % 9.8% 6.8%
Profit Before Exceptional 247.31 162.87
Exceptional Items 1.33 -3.02
Profit Before Tax + 248.64 159.85
Tax Expense 80.50 49.51
Tax % 32.4% 31%
Profit After Tax 168.14 110.34
EPS (Basic) 4.21 2.80

Balance Sheet

Particulars Mar 2026 Mar 2025
ASSETS
Non-Current Assets + 3,368.78 2,877.50
Property, Plant & Equipment 926.49 707.68
Capital Work in Progress 234.36 143.88
Non-Current Investments 0.00 0.00
Goodwill 735.78 734.82
Other Intangible Assets 407.95 447.97
Current Assets + 572.97 794.07
Inventories 94.03 80.27
Trade Receivables 160.91 123.56
Cash and Cash Equivalents 90.55 103.61
Current Investments 152.34 263.73
LIABILITIES & EQUITY
Total Equity 2,119.70 1,926.82
Equity Share Capital 31.68 31.59
Other Equity 1,993.78 1,835.00
Non-Current Liabilities 1,360.57 1,266.99
Current Liabilities 461.48 477.76
Total Liabilities 1,822.05 1,744.75

Cash Flow Statement

Particulars Mar 2026 Mar 2025
Cash from Operating Activities 518.99 360.33
Cash from Investing Activities -308.45 -750.31
Cash from Financing Activities -220.39 381.85
Net Increase/Decrease in Cash -9.85 -8.13